Hospital readmission rates and risk factors for readmission following cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal surface malignancies.

Dreznik, Yael; Hoffman, Aviad; Hamburger, Tamar; Ben-Yaacov, Almog; Dux, Yossi; Jacoby, Harel; Berger, Yaniv; Nissan, Aviram; Gutman, Mordechai

Dreznik, Yael; Hoffman, Aviad; Hamburger, Tamar; Ben-Yaacov, Almog; Dux, Yossi; Jacoby, Harel; Berger, Yaniv; Nissan, Aviram; Gutman, Mordechai.

Afiliação

Dreznik Y; Department of Surgery B, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel. Electronic address: yael.dreznik@sheba.health.gov.il.
Hoffman A; Department of Surgery B, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Hamburger T; Division of Clinical Research, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
Ben-Yaacov A; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of General and Oncological Surgery-Surgery C, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Dux Y; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of General and Oncological Surgery-Surgery C, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Jacoby H; Department of Surgery B, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Berger Y; Department of Surgery B, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Nissan A; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel; Department of General and Oncological Surgery-Surgery C, Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Gutman M; Department of Surgery B, Chaim Sheba Medical Center, Tel-Hashomer, Israel; Affiliated to the Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Surgeon ; 16(5): 278-282, 2018 Oct.

Article em En | MEDLINE | ID: mdl-29429947

Assuntos

Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem; Procedimentos Cirúrgicos de Citorredução/estatística & dados numéricos; Hipertermia Induzida/estatística & dados numéricos; Neoplasias Peritoneais/terapia; Neoplasias Abdominais/tratamento farmacológico; Neoplasias Abdominais/cirurgia; Neoplasias Abdominais/terapia; Procedimentos Cirúrgicos de Citorredução/efeitos adversos; Feminino; Humanos; Hipertermia Induzida/efeitos adversos; Neoplasias Intestinais/tratamento farmacológico; Neoplasias Intestinais/cirurgia; Neoplasias Intestinais/terapia; Masculino; Pessoa de Meia-Idade; Readmissão do Paciente; Neoplasias Peritoneais/tratamento farmacológico; Neoplasias Peritoneais/cirurgia; Complicações Pós-Operatórias/epidemiologia; Estudos Retrospectivos; Medição de Risco; Fatores de Risco

Palavras-chave

CRS/HIPEC; Complications; Readmission

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Peritoneais / Protocolos de Quimioterapia Combinada Antineoplásica / Procedimentos Cirúrgicos de Citorredução / Hipertermia Induzida Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google